Imatinib mesylate can induce molecular remissions in chronic myeloid leukemia

被引：0
|
作者：
Lawler, M
Gately, K
Ryan, J
Carroll, P
Howard, J
Stallings, R
Conneally, E
McCann, S
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [21] Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia
    Alves, Alexandra Rodrigues
    Lima, William Gustavo
    Nagai, Michelly Martins
    Vilela Rodrigues, Joao Paulo
    Ayres, Lorena Rocha
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 52 (04) : 581 - 589
  • [22] Imatinib Mesylate in Newly Diagnosed Patients of Chronic Myeloid Leukemia
    Jacob, L. Abraham
    Bapsy, P. P.
    Babu, K. Govind
    Lokanatha
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 20 - 25
  • [23] Compliance with taking imatinib mesylate in patients with chronic myeloid leukemia in the chronic phase
    Kiguchi, Toru
    Tauchi, Tetsuzo
    Ito, Yoshikazu
    Miyazawa, Keisuke
    Kimura, Yukihiko
    Ohyashiki, Kazuma
    LEUKEMIA RESEARCH, 2009, 33 (03) : 506 - 508
  • [24] Imatinib mesylate in chronic myeloid leukemia of childhood: From care to cure?
    Warrier, Arun
    Santa, Ayyagari
    Sagar, T. G.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 577 - 577
  • [25] Drug Efflux Transporters and Imatinib Mesylate Insensitivity in Chronic Myeloid Leukemia
    Aquino Moreira-Nunes, Caroline Fatima
    Simoes Beltrao, Ana Cristina
    Valente Martins Frances, Larissa Tatiana
    Mattos Amaral Sousa, Rodrigo Guarischi
    Silva, Israel Tojal
    Silva, Artur Luiz
    Silva-, Wilson Araujo, Jr.
    Rodrigues Lemos, Jose Alexandre
    BLOOD, 2012, 120 (21)
  • [26] IMATINIB MESYLATE INDUCED HEPATOTOXICITY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML)
    Milosevic, V.
    Bogdanovic, A.
    Djordjevic, V.
    Fekete, M. Dencic
    Mihaljevic, B.
    Gotic, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 545 - 546
  • [27] Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate
    Arora, B
    Kumar, L
    Sharma, A
    Wadhwa, J
    Kochupillai, V
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 358 - 359
  • [28] Chronic myeloid leukemia in children and adolescents: results of treatment with imatinib mesylate
    Lakshmaiah, K. C.
    Bhise, Rohan
    Purohit, Samit
    Abraham, Linu J.
    Lokanatha, D.
    Suresh, T. M.
    Appaji, L.
    Arunakumari, B. S.
    Govindbabu, K.
    LEUKEMIA & LYMPHOMA, 2012, 53 (12) : 2430 - 2433
  • [29] The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia
    Eskazan, Ahmet Emre
    Elverdi, Tugrul
    Yalniz, Fevzi Firat
    Salihoglu, Ayse
    Ar, Muhlis Cem
    Aydin, Seniz Ongoren
    Baslar, Zafer
    Aydin, Yildiz
    Tuzuner, Nukhet
    Ozbek, Ugur
    Soysal, Teoman
    LEUKEMIA & LYMPHOMA, 2014, 55 (12) : 2935 - 2937
  • [30] Administration of imatinib mesylate in patients with chronic myeloid leukemia with short bowel
    Yamazaki, Rie
    Aisa, Yoshinobu
    Mori, Takehiko
    Iketani, Osamu
    Ikeda, Yasuo
    Okamoto, Shinichiro
    LEUKEMIA & LYMPHOMA, 2009, 50 (04) : 670 - 672
12345